Peregrine Pharmaceuticals

Peregrine Pharma agrees with FDA on lung cancer trial design

Peregrine Pharma agrees with FDA on lung cancer trial design

Reuters

Peregrine Pharmaceuticals Earnings: An Early Look

Peregrine Pharmaceuticals Earnings: An Early Look

Motley Fool

Peregrine's Epic Failure (Maybe)

Peregrine's Epic Failure (Maybe)

Motley Fool

Peregrine Pharma Is Wasting Money On A Placebo Cancer Drug

Peregrine Pharma Is Wasting Money On A Placebo Cancer Drug

TheStreet.com

3 Biotechs Burning Through Cash

3 Biotechs Burning Through Cash

Motley Fool

4 Biotechnology Stocks With Upcoming Catalysts

4 Biotechnology Stocks With Upcoming Catalysts

Seeking Alpha

Peregrine Recovers As Phase II Trial Is Salvaged

Peregrine Recovers As Phase II Trial Is Salvaged

Seeking Alpha

Peregrine Pharmaceuticals Beats Earnings Estimates

Peregrine Pharmaceuticals Beats Earnings Estimates

Seeking Alpha

Is the Risk Worth the Reward for Biotech’s Most Volatile?

Is the Risk Worth the Reward for Biotech’s Most Volatile?

Motley Fool